Atlas FDA

HYLAFORM (HYLAN B GEL); PREVELLE SILK

FDA premarket approval P030032/S012 · decided 2011-07-18

Approval details

PMA number
P030032
Supplement
S012
Supplement type
Real-Time Process
Supplement reason
Change Design/Components/Specifications/Material
Trade name
HYLAFORM (HYLAN B GEL); PREVELLE SILK
Generic name
Implant, dermal, for aesthetic use
Applicant
Genzyme Biosurgery
Date received
2011-05-27
Decision date
2011-07-18
Days to decision
52 days
Decision code
APPR
Product code
LMH
Advisory committee
General, Plastic Surgery
Expedited review
No
Location
Cambridge, MA
Statement
APPROVAL FOR CHANGES IN THE METHODS AND SPECIFICATIONS FOR TESTING THE PREVELLE SILK FINAL PRODUCT (I.E., 1) CHANGING THE AVERAGE EXTRUSION FORCE SPECIFICATIONFROM LESS THAN 80N TO AN AVERAGE OF AVERAGE EXTRUSION FORCE SPECIFICATION OF LESS THAN 40N, 2) CHANGING THE MAXIMUM PEAK EXTRUSION FORCE SPECIFICATION OF LESS THAN 100N TO AN AVERAGE OF MAXIMUM PEAK EXTRUSION FORCE" SPECIFICATION OF LESS THAN 50N AND 3) CHANGING THE METHOD OF DETERMINING THE MAXIMUM PEAK EXTRUSION FORCE SPECIFICATION FROM

Class III intelligence, same tools

PMAs share the API, exports and alerts with 510(k) data - watch an applicant and hear about every approval.

510(k) clearances by this applicant

RecordFirmDate
S-1150 PLEUR-EVAC SAHARA PLUS CONTINUOUS REINFUSION AUTOTRANSFUSION SYSTEM (K031554)Genzyme Biosurgery2003-07-25
MONODEK SYNTHETIC ABSORBABLE SURGICAL SUTURE (K030212)Genzyme Biosurgery2003-03-27
RADLITE TISSUE RETRACTOR SYSTEM (K022989)Genzyme Biosurgery2002-11-25
SAPH-LOOP LIGATING LOOP (K022410)Genzyme Biosurgery2002-08-20